Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.

The potential benefit and risks of dual antiplatelet therapy (DAPT) over single antiplatelet therapy (SAPT) in patients who undergo coronary artery bypass graft surgery (CABG) is controversial.